Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aviyah Peri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Cancer|July 6, 2023
The landscape of T cell antigens for cancer immunotherapyAviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Proteins|July 8, 2010
An integrated suite of fast docking algorithmsEfrat Mashiach, Dina Schneidman-Duhovny, Aviyah Peri, et al.
The Laryngoscope|September 9, 2018
Continuous lumbar drainage and the postoperative complication rate of open anterior skull base surgeryBarak Ringel, Narin N Carmel-Neiderman, Aviyah Peri, et al.
The EMBO Journal|January 31, 2013
Structure-based in silico identification of ubiquitin-binding domains provides insights into the ALIX-V:ubiquitin complex and retrovirus buddingTal Keren-Kaplan, Ilan Attali, Michael Estrin, et al.
Nature Communications|February 16, 2020
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Joo Sang Lee, Eilon Barnea, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Cancer|July 6, 2023
The landscape of T cell antigens for cancer immunotherapyAviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Proteins|July 8, 2010
An integrated suite of fast docking algorithmsEfrat Mashiach, Dina Schneidman-Duhovny, Aviyah Peri, et al.
The Laryngoscope|September 9, 2018
Continuous lumbar drainage and the postoperative complication rate of open anterior skull base surgeryBarak Ringel, Narin N Carmel-Neiderman, Aviyah Peri, et al.
The EMBO Journal|January 31, 2013
Structure-based in silico identification of ubiquitin-binding domains provides insights into the ALIX-V:ubiquitin complex and retrovirus buddingTal Keren-Kaplan, Ilan Attali, Michael Estrin, et al.
Nature Communications|February 16, 2020
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Joo Sang Lee, Eilon Barnea, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
Pageof 1